• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      Pharma Businesses

      Pharma businesses that are rewired will win in the digital era

      13th July 2023

      Featured Chronicle

      ESG

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      The Pros and Cons of Cloud Computing

      The Pros and Cons of Cloud Computing

      13th July 2023
      Let's Read

      Press Room

      Healthcare AI Innovation

      Healthcare AI innovation: a new era of patientcare

      13th July 2023
      Let's Understand

      Article

      Electric Vehicle Thermal Management System (EVTMS) Market

      19th May 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Pharmaceutical Icon

Immunotherapy Drugs Market – Trends Forecast Till 2030

Immunotherapy Drugs Market, By Drug Type (Monoclonal Antibodies, Immunomodulators), By Indication (Infectious Diseases, Cancer) and by Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

  • Published Date : June 2023
  • Base Year Estimate : 2022
  • Report ID : D-PH-IDM-1359
  • Format :
  • Number of Pages : 570
  • Domain : Pharmaceutical
  1. Pharmaceutical
  2. Immunotherapy Drugs Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Immunotherapy Drugs Market size is projected to reach a CAGR of 11.7% from 2023-2030.

Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.

The global immunotherapy market is driven by the increasing adoption of targeted therapies, the increase in the life span of patients, and the high prevalence of lifestyle diseases. Furthermore, rapid approval of drugs and reduction in the recurrence of diseases propel market growth. Additionally, immunotherapy as an alternative to chemotherapy and the use of immunotherapy as the first line of drug for the treatment of cancer provide growth opportunities for the market players shortly.

On the other hand, the high cost of immunotherapy treatment and higher attrition rate in the product development cycle impede market growth.

COVID-19 had a positive impact on the immunotherapy drugs market. Because several businesses are actively engaged in creating immunotherapy-based medications or vaccines for COVID-19, the influence of COVID-19 on the immunotherapy drugs industry is positive. BioNTech SE is now undertaking phase III clinical research in healthy volunteers to examine the safety, tolerability, and immunogenicity of BNT162b2 against COVID-19 in partnership with Pfizer Inc.

Delvens Industry Expert's Standpoint

The global immunotherapy drugs market is anticipated to grow owing to the increasing R&D activities aimed at developing novel immunotherapies for various chronic diseases. The market is expected to grow during the forecast period due to the rising demand for these drugs.

However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle may impede the growth of the market. Despite this, the market is expected to experience significant growth in the coming years, driven by factors such as increasing investments in R&D, growing awareness among patients about the benefits of immunotherapy, and the development of more cost-effective treatment options.

Market Portfolio

Key Findings

  • Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.
     
  • The indication segment is further fragmented into Cancer, Autoimmune Diseases, Infectious Diseases, and Others. The cancer segment accounted for the largest revenue share owing to the increased prevalence of cancer, coupled with a rise in the launch of cancer immunotherapies.
     
  • The drug type segment is further fragmented into monoclonal antibodies, immunomodulators, and vaccines. The monoclonal antibodies segment accounted for the largest share owing to increased R&D in therapeutic monoclonal antibodies coupled with supportive government initiatives.
     
  • The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America dominated the global industry and accounted for the largest share of the overall revenue. The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.

Regional Analysis

North America to Dominate the Market

  • North America dominated the global industry and accounted for the largest share of the overall revenue.
     
  • The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.

Competitive Landscape

  • Amgen, Inc.
  • Novartis AG
  • AbbVie, Inc.
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • AstraZeneca
  • GSK
  • Sanofi
  • Bayer AG